
Havrix 0.5ml Vaccine
Salt Composition: Inactivated Hepatitis A Vaccine(Adsorbed)
Expiry Date: 01/2028
Inclusive of all taxes
1 Vial in a Pack

Havrix 0.5ml Vaccine
1 Vial in a Pack
Inactivated Hepatitis A Vaccine(Adsorbed)
Salt Composition
Inactivated Hepatitis A Vaccine(Adsorbed)
Storage
2–8°C
Expiry Date
01/2028
Marketer
Glaxo SmithKline Pharmaceuticals Ltd
Brand
Havrix

Zuvicella 0.5ml Vaccine
1
Inactivated Hepatitis A Vaccine(Adsorbed)
Salt Composition
Inactivated Hepatitis A Vaccine(Adsorbed)
Storage
2–8°C
Expiry Date
01/2028
Marketer
Zuventus Healthcare Ltd
Brand
Zuvicella
5966.png&w=1920&q=75)
MAGIC DEALS
Buy at $54.09
Apply Promo Code
Available CouponsHavrix 0.5ml Vaccine
Inclusive of all taxes
In Stock
Authorized
Global Reach
Verified Logistics
The price displayed is inclusive of applicable taxes. Any additional fee (such as shipping fee, handling and/or platform fee etc.) will be clearly disclosed before you complete your purchase.
About The Product
Hepatitis A
Overview
Havrix 0.5ml Vaccine contains Inactivated Hepatitis A Vaccine as an active ingredient. This vaccine is used to protect against hepatitis A that is a serious liver disease caused by the hepatitis A virus (HAV).
This infection spreads via contact with contaminated water or food. It is administered by a doctor as 2 shots in the form of Vaccine, 6 to 12 months apart and both are needed for long-term protection.
Vaccination is the best way to prevent hepatitis A.
Havrix 0.5ml Vaccine Uses and Indications
Prevention of Hepatitis A infection
Havrix 0.5ml Vaccine Side Effects
Side effects are unwanted symptoms that can occur from any medical treatment. Like other medications, the Havrix 0.5ml Vaccine can also have adverse effects on the body, most of which resolve without the need for medical attention.
Some common side effects include:
Vaccine site reactions (pain, swelling, redness)
Headache
Irritation
Drowsiness
Loss of appetite
Seek medical attention in case of any unusual or severe side effects immediately.
Havrix 0.5ml Vaccine Dosage and How To Take It
Havrix 0.5ml Vaccine is administered by a doctor as 2 shots in the form of Vaccine, 6 to 12 months apart. This vaccination is done in children at the age of 12 months or older.
Also, adults who have not been vaccinated before and want to be protected against hepatitis A can get the vaccine. It is essential to take both shots of vaccine to get the full benefit. However, the number of shots also depends on the type of vaccine.
How Havrix 0.5ml Vaccine Works
Havrix 0.5ml Vaccine contains Inactivated Hepatitis A Vaccine as an active ingredient. It works by activating the immune system to produce antibodies that will fight & damage the virus and destroy hepatitis A infection.
It can be given from children at the age of 12 months to older. Vaccination is the best way to prevent hepatitis A.
Safety Advice for Havrix 0.5ml Vaccine
Do not take Havrix 0.5ml Vaccine without consulting the doctor in case of pregnancy, as it can be unsafe to take it during this period.
Breastfeeding women should discuss the potential risks and benefits of the Havrix 0.5ml Vaccine with their healthcare provider before starting treatment.
Havrix 0.5ml Vaccine may cause side effects such as dizziness or lack of concentration, which could affect your ability to drive. So it's better to avoid driving.
Share your medical history with the doctor before starting the Havrix 0.5ml Vaccine. Do not take it without consulting a doctor if you have any kidney related issue.
Share your medical history with the doctor before starting the Havrix 0.5ml Vaccine. Do not take it without consulting a doctor if you have any liver related issue.
FAQs About Havrix 0.5ml Vaccine
Havrix 0.5ml Vaccine is used to protect against hepatitis A that is a serious liver disease caused by the hepatitis A virus (HAV).
References
Clemens, R., Safary, A., Hepburn, A., Roche, C., Stanbury, W. J., & André, F. E. (1995). Clinical experience with an inactivated hepatitis A vaccine. Journal of infectious diseases , 171 (Supplement_1), S44-S49.
Pellegrini, V., Fineschi, N., Matteucci, G., Marsili, I., Nencioni, L., Puddu, M. ... & Zuckerman, A. J. (1993). Preparation and immunogenicity of an inactivated hepatitis A vaccine. Vaccine , 11 (3), 383-387.
Duff, B., & Duff, P. (1998). Hepatitis A vaccine: ready for prime time. Obstetrics & Gynecology , 91 (3), 468-471.
Fukushima, S., Kiyohara, T., Ishii, K., Nakano, T., & Hamada, A. (2017). Immunogenicity of aluminum-adsorbed hepatitis A vaccine (Havrix®) administered as a third dose after primary doses of Japanese aluminum-free hepatitis A vaccine (Aimmugen®) for Japanese travelers to endemic countries. Vaccine , 35 (47), 6412-6415.
Kaltenböck, A., Dubischar-Kastner, K., Eder, G., Jilg, W., Klade, C., Kollaritsch, H., ... & Schuller, E. (2009). Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX® 1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study. Vaccine , 27 (33), 4483-4489.
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
.jpeg%3FupdatedAt%3D1763121181831&w=128&q=75)